COVID-19 Ontology

Last uploaded: February 25, 2021
Preferred Name

Interferon
Synonyms

Human Fibroblast Interferon

Human Lymphoblastoid Interferon

Human Leukocyte Interferon

IFN

Interferon

interferon

Definitions

Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570)

ID

http://purl.obolibrary.org/obo/NCIT_C20493

ALT_DEFINITION

A biological response modifier (a substance that can improve the body's natural response to infection and disease). Interferons interfere with the division of cancer cells and can slow tumor growth. There are several types of interferons, including interferon-alpha, -beta, and -gamma. These substances are normally produced by the body. They are also made in the laboratory for use in treating cancer and other diseases.

alternative_term

Human Fibroblast Interferon

Human Lymphoblastoid Interferon

Human Leukocyte Interferon

IFN

Interferon

interferon

code

C20493

Contributing_Source

CTRP

definition

Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570)

Display_Name

Interferon

fromBEL

true

fromPubMed

true

imported from

http://purl.obolibrary.org/obo/ncit.owl

in_subset

http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142800

http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977

http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799

label

Interferon

Legacy_Concept_Name

Interferon

oboInOwl:hasDbXRef

https://www.ncbi.nlm.nih.gov/pubmed/32196678

https://www.ncbi.nlm.nih.gov/pubmed/32142938

preferred label

Interferon

Preferred_Name

Interferon

prefixIRI

NCIT:C20493

prefLabel

Interferon

Semantic_Type

Amino Acid, Peptide, or Protein

Immunologic Factor

textual definition

Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570)

UMLS_CUI

C0021747

subClassOf

http://purl.obolibrary.org/obo/PR_000000001

Delete Subject Author Type Created
No notes to display
Create mapping

Mapping To Ontology Source
http://purl.obolibrary.org/obo/NCIT_C20493 BERO SAME_URI
http://purl.obolibrary.org/obo/CHEBI_52999 CHEBI LOOM
http://www.semanticweb.org/zchero/ontologies/2023/11/SepsisOntology#Interferon SEPON LOOM
http://www.co-ode.org/ontologies/galen#Interferon GALEN LOOM
https://w3id.org/codo#COVIDRO_Interferon CODO LOOM
http://purl.obolibrary.org/obo/BE_Interferon BE LOOM
http://purl.bioontology.org/ontology/CSP/1553-6680 CRISP LOOM
http://purl.bioontology.org/ontology/LNC/LP16468-8 LOINC LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000022612 NDFRT LOOM
http://purl.obolibrary.org/obo/NCIT_C20493 BERO LOOM
http://purl.obolibrary.org/obo/IMR_0000027 HOIP LOOM
http://purl.obolibrary.org/obo/IMR_0000027 TXPO LOOM
http://purl.bioontology.org/ontology/LNC/MTHU021353 LOINC LOOM
http://purl.bioontology.org/ontology/SNMI/F-CB500 SNMI LOOM
http://www.projecthalo.com/aura#Interferon AURA LOOM
http://purl.bioontology.org/ontology/VANDF/4019787 VANDF LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0021747 OCHV LOOM
http://purl.jp/bio/4/id/200906086000422990 IOBC LOOM
https://github.com/sap218/coid/blob/master/coid.owl#COID_00810 COID LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/49327004 SNOMEDCT LOOM
http://purl.obolibrary.org/obo/CHEBI_52999 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_52999 CHEBI LOOM
http://scai.fraunhofer.de/CSEO#CSEO_00000878 CSEO LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20493 NCIT LOOM
http://purl.obolibrary.org/obo/FPLX_Interferon FPLX LOOM
http://purl.bioontology.org/ontology/ATC/S01AD05 ATC LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000022612 ODAE LOOM
http://www.stanford.edu/~coulet/phare.owl#Interferon PHARE LOOM